Cargando…
Novel secretion modification region (SMR) peptide exhibits anti-metastatic properties in human breast cancer cells
Breast cancer is the second leading cause of cancer-related mortality in women worldwide, with nearly 90% attributed to metastatic progression. Exosomes containing epithelial–mesenchymal transition (EMT) ‘programs’ transmit pro-metastatic phenotypes. Our group discovered and developed a novel anti-c...
Autores principales: | Huang, Ming-Bo, Brena, Dara, Wu, Jennifer Y., Roth, William W., Owusu, Samuel, Bond, Vincent C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9343421/ https://www.ncbi.nlm.nih.gov/pubmed/35915218 http://dx.doi.org/10.1038/s41598-022-17534-z |
Ejemplares similares
-
SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells
por: Huang, Ming-Bo, et al.
Publicado: (2019) -
Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells
por: Huang, Ming-Bo, et al.
Publicado: (2017) -
Extracellular vesicle-mediated transport: Reprogramming a tumor microenvironment conducive with breast cancer progression and metastasis
por: Brena, Dara, et al.
Publicado: (2021) -
A large scale screening study with a SMR-based BCI: Categorization of BCI users and differences in their SMR activity
por: Sannelli, Claudia, et al.
Publicado: (2019) -
The Enigmatic Roles of PPR‐SMR Proteins in Plants
por: Zhang, Yi, et al.
Publicado: (2019)